Comparison of Different Materials Contribution to Implants Stability

March 4, 2019 updated by: Gökhan Gürses, Necmettin Erbakan University

Comparison of Different Materials Contribution to Immediate Implants Stability With Resonance Frequency Analysis

The investigators will use two types of material(PRF-Xenograft) in the buccal gap after immediate dental implant placement. The study design has three groups PRF, graft, and control group. The patients will randomly be assigned to groups by envelop method. The resonance frequency analysis device(Osstell) will be used to measure primary and secondary stabilization. Then the investigators will evaluate each materials' contribution to stability.

Pre-op and 9th month Post-op CBCTs will evaluate about bone loss in mesial-distal and horizontal dimensions.

Study Overview

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Konya, Turkey
        • Necmettin Erbakan University, Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • medically healthy,
  • only one maxillary aesthetic region(incisors or premolars) tooth which has two adjacent teeth is indicated for extraction.
  • intact buccal socket walls
  • the gap between buccal socket wall to implant sholder at least 2 mm.

Exclusion Criteria:

  • relevant tooth has more than one root,
  • smoking,
  • alcohol abuse,
  • pregnancy,
  • immune-suppressive patients,
  • any systemic disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PRF Group
PRF is will be used in immediate dental implant placement.
filling the buccal gap with platelet-rich fibrin after immediate dental implant placement
extraction of tooth which is unrestorable
putting dental implant into a socket which has been prepared with compatible drills
placing collagen membran on extraction socket after dental implant placement to cover all
raising the buccal flap with two vertical incision to cover extraction socket for primary closure
Experimental: Graft Group
The xenogenic graft is will be used in immediate dental implant placement.
extraction of tooth which is unrestorable
putting dental implant into a socket which has been prepared with compatible drills
placing collagen membran on extraction socket after dental implant placement to cover all
raising the buccal flap with two vertical incision to cover extraction socket for primary closure
filling the buccal gap with xenogenic graft after immediate dental implant placement
Experimental: Control Group
No extra material is will be used in immediate dental implant placement.
extraction of tooth which is unrestorable
putting dental implant into a socket which has been prepared with compatible drills
placing collagen membran on extraction socket after dental implant placement to cover all
raising the buccal flap with two vertical incision to cover extraction socket for primary closure
filling the buccal gap with no material after immediate dental implant placement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primer Stabilization-Resonance Frequency Analysis
Time Frame: at 0 day
initial measurement after placement by Osstell device
at 0 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Seconder Stabilization-Resonance Frequency Analysis
Time Frame: 120th day
secondary measurement after placement by Osstell device
120th day
Mesial-Distal and Horizontal Bone Loss
Time Frame: 9th month
The alveolar bone loss between first day to 9th month
9th month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Alparslan Esen, Consultant
  • Study Director: Gökhan Gürses, Care Provider

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Actual)

May 31, 2018

Study Completion (Actual)

March 4, 2019

Study Registration Dates

First Submitted

March 23, 2018

First Submitted That Met QC Criteria

April 16, 2018

First Posted (Actual)

April 18, 2018

Study Record Updates

Last Update Posted (Actual)

March 5, 2019

Last Update Submitted That Met QC Criteria

March 4, 2019

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • NecmettinEU-Dentistry

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Implant Failure Nos

Clinical Trials on platelet-rich fibrin placement

Subscribe